| MolName | 6-[(5Z)-5-[1-[2-(benzylamino)-2-oxoethyl]-2-oxoindol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoic acid |
| MolecularFormula | C26H25N3O5S2 |
| Smiles | OC(CCCCCN(C(/C(/S1)=C(\c(cccc2)c2N2CC(NCc3ccccc3)=O)/C2=O)=O)C1=S)=O |
| InChI | InChI=1S/C26H25N3O5S2/c30-20(27-15-17-9-3-1-4-10-17)16-29-19-12-7-6-11-18(19)22(24(29)33)23-25(34)28(26(35)36-23)14-8-2-5-13-21(31)32/h1,3-4,6-7,9-12H,2,5,8,13-16H2,(H,27,30)(H,31,32) |
| InChIK | XVEBQAOFKALSQI-UHFFFAOYSA-N |
| TotalMolweight | 523.633 |
| Molweight | 523.633 |
| MonoisotopicMass | 523.123562 |
| CLogP | 1.6039 |
| CLogS | -4.676 |
| H Acceptors | 8 |
| H Donors | 2 |
| TotalSurfaceArea | 384.87 |
| Relative PSA | 0.33598 |
| PolarSurfaceArea | 164.41 |
| Druglikeness | -4.0386 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.58333 |
| Fragments | 1 |
| Non HAtoms | 36 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 10 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 10 |
| Symmetricatoms | 2 |
| Amides | 3 |
| AcidicOxygens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 6-[(5Z)-5-[1-[2-(benzylamino)-2-oxoethyl]-2-oxoindol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoic acid | 2 - 6-[(5Z)-5-[1-[2-(benzylamino)-2-oxoethyl]-2-oxoindol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoic acid